REGCP Q1 2026 Earnings Preferred Dividends Beat Estimates with 74 Surprise NTIP Q1 2026 Earnings Net Loss of 002 Reported Stock Dips 067 Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrowing Losses Overshadowed by Flat Drug Pipeline Solidion Technology Q4 2025 Earnings Continued Losses Amidst No Revenue QCRH Q1 2026 Earnings Strong EPS Beat Offsets Modest Share Decline ISOU Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Confidence